ARS Pharmaceuticals, Inc.
SPRY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671858
No open-market purchases or sales by ARS Pharmaceuticals, Inc. insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $726.0M in total; Third Point is the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding ARS Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 76 | 1 | 74 | −1 |
| Shares | 28.0M | 75.2K | 28.9M | +980.4K (+3.5%) |
| Value | $864.6M | $2.32M | $288.4M | −$573.9M (−66.6%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 275,567 | $2.75M | 0.01% |
| 5AM Venture Management, LLC | 169,748 | $1.69M | 0.34% |
| Marshall Wace North America L.P. | 162,183 | $1.62M | 0.01% |
| Two Sigma Investments, LP | 150,572 | $1.50M | 0.00% |
| Pictet Asset Management SA | 119,551 | $1.19M | 0.00% |
| Renaissance Technologies LLC | 116,600 | $1.16M | 0.00% |
| Walleye Capital LLC | 92,654 | $925.0K | 0.03% |
| Goldman Sachs Group Inc | 54,349 | $543.0K | 0.00% |
| Trexquant Investment LP | 45,216 | $451.0K | 0.04% |
| Two Sigma Advisers, LP | 37,600 | $375.0K | 0.00% |
| Jump Financial, LLC | 32,500 | $324.0K | 0.02% |
| HRT Financial LP | 26,034 | $259.0K | 0.00% |
| Walleye Trading LLC | 18,956 | $189.0K | 0.00% |
| Hohimer Wealth Management, LLC | 17,077 | $170.0K | 0.04% |
| Occudo Quantitative Strategies LP | 16,765 | $167.0K | 0.02% |
| PDT Partners, LLC | 15,592 | $156.0K | 0.01% |
| Metropolitan Life Insurance Co | 6,383 | $63.7K | 0.00% |
| EMC Capital Management | 7,224 | $62.0K | 0.03% |
| Point72 Hong Kong Ltd | 2,782 | $28.0K | 0.00% |
Sold out (20)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Ameriprise Financial Inc | 448,294 | $13.8M |
| Eventide Asset Management, LLC | 371,384 | $11.5M |
| Cormorant Asset Management, LP | 239,099 | $7.39M |
| Baker Bros. Advisors LP | 238,095 | $7.36M |
| Franklin Resources Inc | 224,208 | $6.93M |
| Candriam Luxembourg S.C.A. | 196,557 | $6.07M |
| Point72 Asset Management, L.P. | 192,996 | $5.96M |
| Sphera Funds Management Ltd. | 173,891 | $5.37M |
| Endurant Capital Management LP | 139,124 | $4.30M |
| Ally Bridge Group (NY) LLC | 128,572 | $3.97M |
| Soleus Capital Management, L.P. | 31,306 | $967.0K |
| Victory Capital Management Inc | 28,970 | $895.0K |
| Jane Street Group, LLC | 9,111 | $281.0K |
| Credit Suisse AG | 7,301 | $226.0K |
| Alliancebernstein L.P. | 7,300 | $225.0K |
| Ensign Peak Advisors, Inc | 5,000 | $154.0K |
| O'Shaughnessy Asset Management, LLC | 1,082 | $33.0K |
| Parallel Advisors, LLC | 415 | $13.0K |
| TCI Wealth Advisors, Inc. | 92 | $3.00K |
| Dark Forest Capital Management LP | 18 | $1.00K |
Not filed for Q3 2021 yet (1)
Institutions that held ARS Pharmaceuticals, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 75,201 | $2.32M |